Trial Profile
Effects of vildagliptin (Galvus) on beta-cell function and turnover in humans
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2013
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Glucose metabolism disorders
- Focus Pharmacodynamics
- 24 Apr 2012 New trial record